DOI QR코드

DOI QR Code

Prevalence and molecular characteristics of carbapenem-resistant Escherichia coli isolated from dogs in South Korea

  • Bo-Youn Moon (Bacterial Disease Division, Animal and Plant Quarantine Agency) ;
  • Md. Sekendar Ali (Bacterial Disease Division, Animal and Plant Quarantine Agency) ;
  • Seunghoe Kim (Bacterial Disease Division, Animal and Plant Quarantine Agency) ;
  • Hee-Seung Kang (Bacterial Disease Division, Animal and Plant Quarantine Agency) ;
  • Ye-Ji Kang (Division of Health Hazard Response, Korea Disease Control and Prevention Agency) ;
  • Jae-Myung Kim (Bacterial Disease Division, Animal and Plant Quarantine Agency) ;
  • Dong-Chan Moon (Centre for Infectious Diseases Research, Korea Centers for Disease Control and Prevention) ;
  • Suk-Kyung Lim (Bacterial Disease Division, Animal and Plant Quarantine Agency)
  • 투고 : 2024.06.17
  • 심사 : 2024.08.13
  • 발행 : 2024.09.30

초록

Importance: Carbapenem-resistant Enterobacteriaceae are emerging as a global public health risk. Therefore, assessing the prevalence of carbapenem-resistant Escherichia coli (CRE) in both humans and animals is important. Objective: We aimed to ascertain the occurrence and characteristics of CRE isolated from companion animals, dogs and cats. Methods: E. coli strains were tested for antimicrobial susceptibility using the broth microdilution technique. Antimicrobial resistance genes were detected by polymerase chain reaction and sequencing analysis. The molecular characteristics of CRE were determined using multi-locus sequence typing, replicon typing, and pulsed-field gel electrophoresis (PFGE). Results: In total, 13 CRE isolates (0.13%) were identified from dogs possessing blaNDM-5 along with β-lactamase genes, mostly blaCMY-2 (92.2%) and blaTEM-1 (53.8%). The commonly observed mutations were S83L and D87N in gyrA, S80I in parC, and S458A in parE. CRE carried non-beta-lactam resistance genes, with the majority being tet(B) (100%), sul (84.6%), and aac(3)-II (53.8%). Nine different PFGE patterns (P1-P9), IncX3-type plasmids (69.2%), and ST410 (84.6%) were predominantly detected. Conclusions and Relevance: This investigation provides significant insight into the prevalence and molecular characteristics of blaNDM-5-carrying E. coli in dogs. The co-existence of blaNDM-5 and other antimicrobial resistance genes in E. coli potentially poses severe health hazards to humans.

키워드

과제정보

This study was supported by the Animal and Plant Quarantine Agency, Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea (grant number: B-1543081-2024-26-01).

참고문헌

  1. Teng L, Feng M, Liao S, Zheng Z, Jia C, Zhou X, et al. A cross-sectional study of companion animal-derived multidrug-resistant Escherichia coli in Hangzhou, China. Microbiol Spectr. 2023;11(2):e0211322.
  2. Moon BY, Ali MS, Kwon DH, Heo YE, Hwang YJ, Kim JI, et al. Antimicrobial resistance in Escherichia coli isolated from healthy dogs and cats in South Korea, 2020-2022. Antibiotics (Basel). 2023;13(1):27.
  3. Cole SD, Peak L, Tyson GH, Reimschuessel R, Ceric O, Rankin SC. New Delhi metallo-β-lactamase-5-producing Escherichia coli in companion animals, United States. Emerg Infect Dis. 2020;26(2):381-383.
  4. Xu J, Guo H, Li L, He F. Molecular epidemiology and genomic insights into the transmission of carbapenem-resistant NDM-producing Escherichia coli. Comput Struct Biotechnol J. 2023;21:847-855.
  5. Peterhans S, Stevens MJ, Nuesch-Inderbinen M, Schmitt S, Stephan R, Zurfluh K. First report of a blaNDM-5-harbouring Escherichia coli ST167 isolated from a wound infection in a dog in Switzerland. J Glob Antimicrob Resist. 2018;15:226-227.
  6. Hong JS, Song W, Park HM, Oh JY, Chae JC, Han JI, et al. First detection of New Delhi metallo-β-lactamase-5-producing Escherichia coli from companion animals in Korea. Microb Drug Resist. 2019;25(3):344-349.
  7. Hong JS, Song W, Jeong SH. Molecular characteristics of NDM-5-producing Escherichia coli from a cat and a dog in South Korea. Microb Drug Resist. 2020;26(8):1005-1008.
  8. Kyung SM, Choi SW, Lim J, Shim S, Kim S, Im YB, et al. Comparative genomic analysis of plasmids encoding metallo-β-lactamase NDM-5 in Enterobacterales Korean isolates from companion dogs. Sci Rep. 2022;12(1):1569.
  9. Oh JY, Sum S, Song WK, Park JC. Emergence of blaNDM-5-producing Escherichia coli ST410 in companion dogs treated with meropenem. Pak Vet J. 2020;40(40):534-536.
  10. Choi JH, Ali MS, Moon BY, Kang HY, Kim SJ, Song HJ, et al. Prevalence and characterization of extended-spectrum β-lactamase-producing Escherichia coli isolated from dogs and cats in South Korea. Antibiotics (Basel). 2023;12(4):745.
  11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Seventh Informational Supplement, M100-S25. Clinical and Laboratory Standards Institute; 2020.
  12. Reynolds ME, Phan HTT, George S, Hubbard ATM, Stoesser N, Maciuca IE, et al. Occurrence and characterization of Escherichia coli ST410 co-harbouring blaNDM-5, blaCMY-42 and blaTEM-190 in a dog from the UK. J Antimicrob Chemother. 2019;74(5):1207-1211.
  13. Yousfi M, Touati A, Mairi A, Brasme L, Gharout-Sait A, Guillard T, et al. Emergence of carbapenemaseproducing Escherichia coli isolated from companion animals in Algeria. Microb Drug Resist. 2016;22(4):342-346.
  14. Kim SY, Seo J, Shin J, Chung YJ, Jeon IY, Yun SJ, et al. Clonal spreading of NDM-5 carbapenemaseproducing Escherichia coli isolates in a hospital in South Korea. Diagn Microbiol Infect Dis. 2020;97(2):115027.
  15. Li F, Ye K, Li X, Ye L, Guo L, Wang L, et al. Genetic characterization of carbapenem-resistant Escherichia coli from China, 2015-2017. BMC Microbiol. 2021;21(1):248.
  16. Chung YS, Hu YS, Shin S, Lim SK, Yang SJ, Park YH, et al. Mechanisms of quinolone resistance in Escherichia coli isolated from companion animals, pet-owners, and non-pet-owners. J Vet Sci. 2017;18(4):449-456.
  17. Karczmarczyk M, Abbott Y, Walsh C, Leonard N, Fanning S. Characterization of multidrug-resistant Escherichia coli isolates from animals presenting at a university veterinary hospital. Appl Environ Microbiol. 2011;77(20):7104-7112.
  18. Poirel L, Madec JY, Lupo A, Schink AK, Kieffer N, Nordmann P, et al. Antimicrobial resistance in Escherichia coli. Microbiol Spectr. 2018;6(4).
  19. Wang H, Yan Z, Mu L, Gao XY, Li JY, Hu ZD, et al. Molecular and clinical characteristics of carbapenemresistant Enterobacteriaceae isolates collected at a tertiary hospital in northern China. Trans R Soc Trop Med Hyg. 2023;117(1):55-57.
  20. Pan F, Tian D, Wang B, Zhao W, Qin H, Zhang T, et al. Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai. BMC Infect Dis. 2019;19(1):678.
  21. Shen Y, Hu F, Wang Y, Yin D, Yang L, Chen Y, et al. Transmission of carbapenem resistance between human and animal NDM-positive Escherichia coli Strains. Engineering (Beijing). 2022;15:24-33.
  22. Mouftah SF, Pal T, Darwish D, Ghazawi A, Villa L, Carattoli A, et al. Epidemic IncX3 plasmids spreading carbapenemase genes in the United Arab Emirates and worldwide. Infect Drug Resist. 2019;12:1729-1742.